ADHD Medications Linked to Reduced Maladaptive Daydreaming and Mind-Wandering in Adults
Bioengineer.org
Adults with ADHD who took either methylphenidate or atomoxetine showed significant reductions in maladaptive daydreaming and mind-wandering over 12 weeks of treatment, with the most improvement occurring in the first four weeks. Both medications were similarly effective in reducing these symptoms, and higher baseline maladaptive daydreaming was linked to greater reductions in both maladaptive daydreaming and mind-wandering.
All articles from 29 October 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.